Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Imaging
    • Nanotechnology
    • Semiconductors
  • Controlled Environments
    • Cleanrooms
    • Graphene
    • Lasers
    • Regulations/Standards
    • Sensors
  • Scientific Computing
    • Big Data
    • HPC/Supercomputing
    • Informatics
    • Security
    • Software
  • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
    • R&D 100 Conference
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • 2020 Funding Forecast
  • COVID-19

Bill Gates Gives $50M to Combat Alzheimer’s

By The Associated Press | November 14, 2017

In this Monday, Feb. 22, 2016 file photo, Bill Gates talks to reporters about the 2016 annual letter from the Bill and Melinda Gates Foundation in New York. Gates says he’s giving $50 million to help fight Alzheimer’s disease. The Microsoft co-founder said Monday, Nov. 13, 2017, that the donation to the Dementia Discovery Fund is personal and not through his charitable foundation. (AP Photo/Seth Wenig)

Bill Gates says he’s giving $50 million to help fight Alzheimer’s disease.

The Microsoft co-founder said Monday that the donation to the Dementia Discovery Fund is personal and not through his charitable foundation.

The London-based private fund is backed by government, charities and pharmaceutical firms and seeks new treatments for the progressive, irreversible neurological disease.

In a statement , Gates says men in his family have suffered from Alzheimer’s. He says he’s hopeful that in time Alzheimer’s could be a chronic condition treatable with medication.

Gates says the first treatments for the disease might not be feasible for a decade or more and would initially be expensive. He says the Gates Foundation might consider how to expand access in poorer countries when treatments are developed.

Related Articles Read More >

Lawrence Livermore National Lab and UK company to collaborate on universal coronavirus vaccine
ZEISS announces collaborative research partnership with Max Planck Florida Institute for Neuroscience
R&D 100 winner of the day: MilliporeSigma Blazar Platform
AI-powered microscope could check cancer margins in minutes

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup
Tweets by @RandDWorld

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2020 Global Funding Forecast

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Imaging
    • Nanotechnology
    • Semiconductors
  • Controlled Environments
    • Cleanrooms
    • Graphene
    • Lasers
    • Regulations/Standards
    • Sensors
  • Scientific Computing
    • Big Data
    • HPC/Supercomputing
    • Informatics
    • Security
    • Software
  • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
    • R&D 100 Conference
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • 2020 Funding Forecast
  • COVID-19